Project Grant HT94252510933
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $450K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
- The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...
- The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,297,895 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying immunomodulatory targets of TAZ/SRF in sarcomatoid renal cell carcinoma progression. This 4-year research project, which commenced on September 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public by...
- The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...
- This Project Grant award, totaling $1,229,936, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas Southwestern Medical Center, doing business as Southwestern Medical School, located in Dallas, Texas. The award supports research aimed at "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC" over the project period from August 1, 2025 to July...
- The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
- The University of Texas Southwestern Medical Center in Dallas, TX was awarded a $319,693 Project Grant on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate the mechanism of selective HIF-2 regulation of PTHrP and hypercalcemia in clear cell renal carcinoma. This work aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
- The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...